|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Crinò L, Weder W, van Meerbeeck J and
Felip E; ESMO Guidelines Working Group, : Early stage and locally
advanced (non-metastatic) non-small-cell lung cancer: ESMO clinical
practice guidelines for diagnosis, treatment and follow-up. Ann
Oncol. 21 (Suppl 5):v103–v115. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zago G, Muller M, van den Heuvel M and
Baas P: New targeted treatments for non-small-cell lung cancer-role
of nivolumab. Biologics. 10:103–117. 2016.PubMed/NCBI
|
|
4
|
Lo RG, Imbimbo M and Garassino MC: Is the
chemotherapy era in advanced non-small cell lung cancer really
over? Maybe not yet. Tumori. 2016:223–225. 2016.PubMed/NCBI
|
|
5
|
Tamura T, Kurishima K, Nakazawa K,
Kagohashi K, Ishikawa H, Satoh H and Hizawa N: Specific organ
metastases and survival in metastatic non-small-cell lung cancer.
Mol Clin Oncol. 3:217–221. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Riihimäki M, Hemminki A, Fallah M, Thomsen
H, Sundquist K, Sundquist J and Hemminki K: Metastatic sites and
survival in lung cancer. Lung Cancer. 86:78–84. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morgensztern D, Ng SH, Gao F and Govindan
R: Trends in stage distribution for patients with non-small cell
lung cancer: A national cancer database survey. J Thorac Oncol.
5:29–33. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Detterbeck FC, Boffa DJ, Kim AW and Tanoue
LT: The eighth edition lung cancer stage classification. Chest.
151:193–203. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Eberhardt WE, Mitchell A, Crowley J, Kondo
H, Kim YT, Turrisi AR III, Goldstraw P and Rami-Porta R;
International Association for Study of Lung Cancer Staging and
Prognostic Factors Committee, Advisory Board Members, Participating
Institutions, : The IASLC lung cancer staging project: Proposals
for the revision of the M descriptors in the forthcoming eighth
edition of the TNM classification of lung cancer. J Thorac Oncol.
10:1515–1522. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chang YP, Chen YM, Lai CH, Lin CY, Fang
WF, Huang CH, Li SH, Chen HC, Wang CC and Lin MC: The impact of de
novo liver metastasis on clinical outcome in patients with advanced
non-small-cell lung cancer. PLoS One. 12:e1786762017.
|
|
11
|
Ren Y, Dai C, Zheng H, Zhou F, She Y,
Jiang G, Fei K, Yang P, Xie D and Chen C: Prognostic effect of
liver metastasis in lung cancer patients with distant metastasis.
Oncotarget. 7:53245–53253. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Surveillance, Epidemiology, and End
Results (SEER) Program, . About the SEER program. http://www.seer.cancer.govJanuary
20–2017
|
|
13
|
Abdel-Rahman O: Validation of the
prognostic value of new sub-stages within the AJCC 8th edition of
non-small cell lung cancer. Clin Transl Oncol. 19:1414–1420. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Postmus PE, Brambilla E, Chansky K,
Crowley J, Goldstraw P, Patz EJ Jr and Yokomise H; International
Association for the Study of Lung Cancer International Staging
Committee; Cancer Research and Biostatistics; Observers to the
Committee, Participating Institutions, : The IASLC lung cancer
staging project: Proposals for revision of the M descriptors in the
forthcoming (seventh) edition of the TNM classification of lung
cancer. J Thorac Oncol. 2:686–693. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Griffioen GH, Toguri D, Dahele M, Warner
A, de Haan PF, Rodrigues GB, Slotman BJ, Yaremko BP, Senan S and
Palma DA: Radical treatment of synchronous oligometastatic
non-small cell lung carcinoma (NSCLC): Patient outcomes and
prognostic factors. Lung Cancer. 82:95–102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kuchuk M, Kuchuk I, Sabri E, Hutton B,
Clemons M and Wheatley-Price P: The incidence and clinical impact
of bone metastases in non-small cell lung cancer. Lung Cancer.
89:197–202. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Derks JL, Hendriks LE, Buikhuisen WA,
Groen HJ, Thunnissen E, van Suylen RJ, Houben R, Damhuis RA, Speel
EJ and Dingemans AM: Clinical features of large cell neuroendocrine
carcinoma: A population-based overview. Eur Respir J. 47:615–624.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Milovanovic IS, Stjepanovic M and Mitrovic
D: Distribution patterns of the metastases of the lung carcinoma in
relation to histological type of the primary tumor: An autopsy
study. Ann Thorac Med. 12:191–198. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gibson A, Li H, D'Silva A, Tudor RA,
Elegbede AA, Otsuka SM, Bebb DG and Cheung WY: Impact of number
versus location of metastases on survival in stage IV M1b non-small
cell lung cancer. Med Oncol. 35:1172018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu KL, Tsai MJ, Yang CJ, Chang WA, Hung
JY, Yen CJ, Shen CH, Kuo TY, Lee JY, Chou SH, et al: Liver
metastasis predicts poorer prognosis in stage IV lung
adenocarcinoma patients receiving first-line gefitinib. Lung
Cancer. 88:187–194. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dong F, Shen Y, Gao F, Xu T, Wang X, Zhang
X, Zhong S, Zhang M, Chen S and Shen Z: Prognostic value of
site-specific metastases and therapeutic roles of surgery for
patients with metastatic bladder cancer: A population-based study.
Cancer Manag Res. 9:611–626. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cai H, Wang H, Li Z, Lin J and Yu J: The
prognostic analysis of different metastatic patterns in
extensive-stage small-cell lung cancer patients: A large
population-based study. Future Oncol. 14:1397–1407. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Paz-Ares LG, Shen K, Higgs BW, Morehouse
C, Rizvi NA, Segal NH, Jin X, Zheng Y, Narwal R, Gupta AK, et al:
Association of liver metastases (LM) with survival in NSCLC
patients treated with durvalumab (D) in two independent clinical
trials. J Clin Oncol. 15:30382017. View Article : Google Scholar
|
|
24
|
Pillai RN, Kamphorst AO, Owonikoko TK,
Behera M, Behera S, Khuri FR, Ahmed R and Ramalingam SS: Liver
metastases and sensitivity to checkpoint inhibition in patients
with non-small cell lung cancer (NSCLC). J Clin Oncol.
15:e206652016. View Article : Google Scholar
|
|
25
|
Tumeh PC, Hellmann MD, Hamid O, Tsai KK,
Loo KL, Gubens MA, Rosenblum M, Harview CL, Taube JM, Handley N, et
al: Liver metastasis and treatment outcome with anti-PD-1
monoclonal antibody in patients with melanoma and NSCLC. Cancer
Immunol Res. 5:417–424. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Socinski MA, Jotte RM, Cappuzzo F, Orlandi
F, Stroyakovskiy D, Nogami N, Rodriguez-Abreu D, Moro-Sibilot D,
Thomas CA, Barlesi F, et al: Atezolizumab for first-line treatment
of metastatic nonsquamous NSCLC. N Engl J Med. 378:2288–2301. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu B, Wei S, Tian J, Song X, Hu P and Cui
Y: Comparison of the survival time in the non-small cell lung
cancer patients with different organ metastasis. Zhongguo Fei Ai Za
Zhi. 22:105–110. 2019.(In Chinese). PubMed/NCBI
|
|
28
|
Yang J, Zhang Y, Sun X, Gusdon AM, Song N,
Chen L, Jiang G and Huang Y: The prognostic value of multiorgan
metastases in patients with non-small cell lung cancer and its
variants: A SEER-based study. J Cancer Res Clin Oncol.
144:1835–1842. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
He YY, Zhang XC, Yang JJ, Niu FY, Zeng Z,
Yan HH, Xu CR, Guan JL, Zhong WZ, Yang LL, et al: Prognostic
significance of genotype and number of metastatic sites in advanced
non-small-cell lung cancer. Clin Lung Cancer. 15:441–447. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Blumenthal GM, Zhang L, Zhang H,
Kazandjian D, Khozin S, Tang S, Goldberg K, Sridhara R, Keegan P
and Pazdur R: Milestone analyses of immune checkpoint inhibitors,
targeted therapy, and conventional therapy in metastatic non-small
cell lung cancer trials: A meta-analysis. JAMA Oncol.
3:e1710292017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
